Haemonetics Corporation vs. Stryker Corporation
Stryker Corporation (SYK) comes out ahead, leading on 8 of 9 compared factors.
Size & Scale
| HAE | SYK | |
|---|---|---|
| Market Cap | $4.68 billion | $106.03 billion |
| Revenue (TTM) | $1.35 billion | $25.84 billion |
| Net Income (TTM) | $96.29 million | $3.73 billion |
SYK leads on 3 of 3 size & scale factors.
Valuation
| HAE | SYK | |
|---|---|---|
| P/E Ratio | 49.68 | 28.65 |
| Price / Book | 5.59 | 4.42 |
| Price / Sales | 3.46 | 4.10 |
SYK leads on 2 of 3 valuation factors.
Profitability
| HAE | SYK | |
|---|---|---|
| Net Margin | 7.12% | 14.43% |
| Return on Equity | 11.50% | 15.55% |
SYK leads on 2 of 2 profitability factors.
Dividend
| HAE | SYK | |
|---|---|---|
| Dividend Yield | — | 1.27% |
| Payout Ratio | — | 36.48 |
HAE and SYK split the dividend factors evenly.
Risk & Sentiment
| HAE | SYK | |
|---|---|---|
| Short Interest | 1.81% | 1.53% |
SYK leads on 1 of 1 risk & sentiment factors.
Dig deeper: HAE overview, HAE financials, SYK overview, SYK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.